XML 70 R59.htm IDEA: XBRL DOCUMENT v3.19.2
Stock Based Compensation - Omnibus Incentive Plan (Details) - Omnibus Plan - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 25, 2017
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Oct. 31, 2015
Weighted-Average Grant Date Fair Value            
Compensation expense   $ 161 $ 389 $ 308 $ 784  
Stock Options            
Stock based compensation            
Number of shares authorized 1,200,000         800,000
Number of additional shares authorized 400,000          
Number of shares available for grant   204,100   204,100    
Stock options granted (in shares)       0    
Number of shares            
Balance at beginning of year (in shares)       910,627    
Granted (in shares)       0    
Forfeited (in shares)       (46,370)    
Balance at end of year (in shares)   864,257   864,257    
Options: Options vested and exercisable   344,148   344,148    
Options: Options vested and expected to vest   864,257   864,257    
Weighted-Average Exercise Price            
Balance at beginning of year (in dollars per share)       $ 14.99    
Granted (in dollars per share)     $ 1.65 0.00    
Forfeited (in dollars per share)       11.52    
Balance at end of year (in dollars per share)   $ 15.17   15.17    
Weighted-Average Exercise Price: Options vested and exercisable   22.23   22.23    
Weighted-Average Exercise Price: Options vested and expected to vest   $ 15.17   $ 15.17    
Weighted- Average Remaining Contractual Term (in Years)            
Balance (in years)       7 years 10 months 17 days    
Weighted-Average Remaining Contractual Term (in Years): Options vested and exercisable       7 years 5 months 19 days    
Weighted-Average Remaining Contractual Term (in Years): Options vested and expected to vest       7 years 10 months 17 days    
Number of unvested options scheduled to vest            
Non-Vested Options as of beginning of period       605,352    
Granted (in shares)       0    
Forfeited (in shares)       (28,791)    
Vested (in shares)       (56,452)    
Non-Vested Options as of end of period   520,109   520,109    
Weighted-Average Grant Date Fair Value            
Non-Vested, beginning balance       $ 3.14    
Forfeited: Weighted-Average Grant Date Fair Value       2.51    
Vested: Weighted-Average Grant Date Fair Value       3.76    
Non-Vested, ending balance   $ 3.11   $ 3.11    
2019 | Stock Options            
Number of unvested options scheduled to vest            
Non-Vested Options as of end of period   231,906   231,906    
2020 | Stock Options            
Number of unvested options scheduled to vest            
Non-Vested Options as of end of period   236,503   236,503    
2021 | Stock Options            
Number of unvested options scheduled to vest            
Non-Vested Options as of end of period   51,700   51,700